Pharmacological management of sleep apnea and obesity, a new frontier
They thereby exceed considerably their original purpose, which was to document that the drugs do not increase cardiovascular risk
Like, Oh my God, I have to inject myself with something just to get my fat a-- to stop eating
Figures and comparison tables of GLP-1RAs provide valuable insights into dosing frequency, main use, weight loss efficacy, and blood sugar control, assisting healthcare professionals and patients in choosing the most appropriate treatment based on therapeutic goals and individual needs
Both obesity and diabetes, which are treated by GLP-1 drugs, are major risk factors for Alzheimers
The ideal choices share several characteristics: they promote muscle preservation during caloric deficit, they enhance rather than impair fat oxidation, they produce minimal water retention, and they have manageable side effect profiles when used responsibly
